Arquivamento - Art. 36 §1° da LPI
#11.2
05/10/2022
RPI 2679
Application data
Number
112018075645Type
Filing
Publication
PCT
US2017036399 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 05/10/2022. We update with every new RPI gazette, published weekly.
Applicants
ABBVIE INC.
US
Inventors
A. P. (pessoa física)
US
A. S. (pessoa física)
US
A. J. (pessoa física)
US
E. B. (pessoa física)
US
M. B. (pessoa física)
US
IPC Classification
Priority claims
US
62/347,258 · 06/08/2016
US
62/347,528 · 06/08/2016
Abstract
A invenção se refere a conjugados anticorpo fármaco (CAFs) anti-Receptor do Fator de Crescimento Epidérmico (EGFR) que inibem Bcl-xL, incluindo composi-ções e métodos de uso dos ditos CAFs.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
05/10/2022
RPI 2679
#6.23
02/01/2022
RPI 2665
#15.35
09/21/2021
RPI 2646
#1.3
04/24/2019
RPI 2520
#1.3.2
Anulada a publicação código 1.3 na RPI nº 2518 de 09/04/2019 por ter sido indevida.
04/16/2019
RPI 2519
#1.3
04/09/2019
RPI 2518
#1.1
12/18/2018
RPI 2502
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.